The Treatment Patterns with Brolucizumab in Germany (REALIZE) Study: A Retrospective Cohort Study Based on Longitudinal Prescription Data

INTRODUCTION: This study describes real-world treatment patterns in Germany for brolucizumab, an anti-vascular endothelial growth factor (anti-VEGF) therapy for neovascular age-related macular degeneration (nAMD). METHODS: This single-arm retrospective cohort study used German patient-level prescrip...

Descripción completa

Detalles Bibliográficos
Autores principales: Liegl, Raffael G., Karcher, Helene, Chetty-Mhlanga, Shala, Igwe, Franklin, Freitas, Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834462/
https://www.ncbi.nlm.nih.gov/pubmed/36327000
http://dx.doi.org/10.1007/s40123-022-00596-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834462/
https://www.ncbi.nlm.nih.gov/pubmed/36327000
http://dx.doi.org/10.1007/s40123-022-00596-7

Ejemplares similares